Tokyo, June 4 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061777) titled 'Study on Body Composition and Clinical Course in Patients Undergoing Catheter Ablation for Atrial Fibrillation' on June 3.
Study Type:
Observational
Primary Sponsor:
Institute - Hokkaido Cardiovascular Hospital
Condition:
Condition - Atrial fibrillation
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To prospectively investigate the association between body composition assessed by InBody, left atrial electrical substrate including low-voltage areas, and clinical outcomes after first-time catheter ablation in patients with atrial fibrillation.
Basic objectives2 - Others
Eligibility:
Age-lower limit - 20
years-old
=
Gender - Male and Female
Key inclusion criteria - 1. Patients scheduled to undergo first-time catheter ablation for atrial fibrillation.
2. Patients who provide written informed consent to participate in this study.
3. Patients aged 20 years or older at the time of informed consent.
Key exclusion criteria - 1. Patients who have previously undergone catheter ablation for atrial fibrillation.
2. Patients who do not provide informed consent to participate in this study.
3. Patients judged by the principal investigator or attending physician to be unsuitable for participation in this study.
Target Size - 200
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2026 Year 06 Month 01 Day
Date of IRB - 2026 Year 05 Month 28 Day
Anticipated trial start date - 2026 Year 06 Month 03 Day
Last follow-up date - 2028 Year 12 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000070647
Disclaimer: Curated by HT Syndication.
